{ "resourceType" : "ActivityDefinition", "id" : "chf-lasix-iv", "meta" : { "profile" : ["http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-computableactivity"] }, "text" : { "status" : "extensions", "div" : "
Generated Narrative: ActivityDefinition
Resource ActivityDefinition "chf-lasix-iv"
Profile: CPG Computable Activity Definition
CQF Knowledge capability: shareable
CQF Knowledge capability: computable
CQF Knowledge capability: publishable
CQF knowledge representation level: structured
StructureDefinition Work Group: cds
url: http://hl7.org/fhir/uv/cpg/ActivityDefinition/chf-lasix-iv
version: 2.0.0-ballot
name: CHFLASIXIV
status: active
experimental: true
date: 2023-12-19 06:22:49+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description: Activity definition to administer LASIX IV as part of a congestive heart failure pathway
jurisdiction: World (m49.htm#001)
kind: MedicationRequest
profile: CPG Medicaiton Request
code: Order a medication (CPG Activity Type Code System#order-medication)
intent: proposal
priority: routine
doNotPerform: false
product: LASIX IV (CHF Codes#lasix-iv)
dosage
sequence: 1
text: 40mg
timing: Once per 1 days
route: Intravenous Route (qualifier value) (SNOMED CT#47625008)
doseAndRate